Models of acute myeloid leukemia: Prospects for drug development and testing

Drug Discovery Today: Disease Models

Volumn 3, Issue 2, 2006, Pages 137-142

  Yin, Bin ^a   Largaespada, David A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CRE RECOMBINASE; FLT3 LIGAND; MIXED LINEAGE LEUKEMIA PROTEIN; MYC PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOIC ACID; TRANSCRIPTION FACTOR RUNX1;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER CELL CULTURE; CANCER MODEL; CANCER RADIOTHERAPY; CANCER RESISTANCE; CHROMOSOME TRANSLOCATION; COMPUTER MODEL; DRUG EFFICACY; DRUG RESEARCH; DRUG RESPONSE; GENE INTERACTION; GENE MUTATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; LEUKEMIA CELL LINE; LEUKEMIA RELAPSE; LEUKEMOGENESIS; MATHEMATICAL MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; REVIEW; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; THERAPY RESISTANCE; TRANSGENIC MOUSE; TUMOR XENOGRAFT;

EID: 33747440418     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2006.05.002     Document Type: Review

References (20)

1. Rowe J.M. What is the best induction regimen for acute myelogenous leukemia?. Leukemia 12 Suppl. 1 (1998) S16-S19
2. Drexler H.G., et al. False leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia 17 (2003) 416-426
3. Andersson A., et al. Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations. Leukemia 19 (2005) 1042-1050
4. Largaespada D.A., et al. Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels. J. Virol. 69 (1995) 5095-5102
5. Yin B., et al. Nf1 gene inactivation in acute myeloid leukemia cells confers cytarabine resistance through MAPK and mTOR pathways. Leukemia 20 (2006) 151-154
6. Zhan X., et al. Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro. Lancet 364 (2004) 163-171
7. Bonnet D., and Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3 (1997) 730-737
8. Guzman M.L., et al. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 105 (2005) 4163-4169
9. McCormack E., et al. Animal models of acute myelogenous leukaemia-development, application and future perspectives. Leukemia 19 (2005) 687-706
10. Corral J., et al. An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell 85 (1996) 853-861
11. Higuchi M., et al. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell 1 (2002) 63-74
12. Drynan L.F., et al. Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis. EMBO J. 24 (2005) 3136-3146
13. Sohal J., et al. A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657. Blood 101 (2003) 3188-3197
14. Largaespada D.A. Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies. Leukemia 14 (2000) 1174-1184
15. Kawakami K. Transposon tools and methods in zebrafish. Dev. Dyn. 234 (2005) 244-254
16. Langenau D.M., et al. Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukaemia. Proc. Natl. Acad. Sci. U S A 102 (2005) 6068-6073
17. Stern H.M., et al. Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nat. Chem. Biol. 1 (2005) 366-370
18. Ma'ayan A., et al. Formation of regulatory patterns during signal propagation in a Mammalian cellular network. Science 309 (2005) 1078-1083
19. Komarova N.L., and Wodarz D. Drug resistance in cancer: principles of emergence and prevention. Proc. Natl. Acad. Sci. U S A 102 (2005) 9714-9719
20. Yin B., et al. Trp53 loss during in vitro selection contributes to acquired Ara-C resistance in acute myeloid leukemia. Exp. Hematol. 34 (2006) 631-641